The Second Window of Preconditioning (SWOP) Where Are We Now?

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.3, 2010-06, pp. : 235-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermediate care – where are we now?

By Harari Danielle

Clinical Medicine, Vol. 2, Iss. 5, 2002-09 ,pp. : 477-479

Royal College Of Physicians

Access to resources Recommend Favorite

Discovery and ADMET: Where Are We Now

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?

By Singhal Pankaj Lele Shashikant

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 941-946

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Antiatherosclerotic Effects of ACE Inhibitors: Where Are We Now?

By Lonn E.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 5, 2001-01 ,pp. : 315-320

Adis International

Access to resources Recommend Favorite

Editorial: [Hot Topic: Molecular Pathology in Therapeutics: Where are We Now, and Where are We Going?]

Current Drug Targets, Vol. 13, Iss. 12, 2012-11 ,pp. : 1473-1474

Bentham Science Publishers

Access to resources Recommend Favorite